NSE ScannerComparison · NSE · data 2026-11-01
Blue Jet Healthcare Limited vs Strides Pharma Science Ltd
In plain words
Size: Strides Pharma Science Ltd is about 1 times the market value of Blue Jet Healthcare Limited.
Valuation (P/E): Blue Jet Healthcare Limited 37.3 vs Strides Pharma Science Ltd 16.
Debt to equity: Strides Pharma Science Ltd 0.57 vs Blue Jet Healthcare Limited 0.03.
Differences in the numbers, not a recommendation of either stock.
Side by side
| BLUEJET | STAR | |
|---|---|---|
| Price | ₹504.55 | ₹1,068.8 |
| Market cap | ₹9,547 cr | ₹9,855 cr |
| P/E | 37.3 | 16 |
| P/B | — | 2.9 |
| ROE | 19.9% | 19.7% |
| ROCE | 21.1% | 15.1% |
| Debt / equity | 0.03 | 0.57 |
| Operating margin | 27.8% | 14.2% |
| Dividend yield | 0.24% | 0.47% |
| Sales growth, 3 years (yearly) | 9.5% | 9.2% |
| Profit growth, 3 years (yearly) | 15.7% | — |
| 1-year return | -22.9% | 24.7% |
| Revenue, last 12 months | ₹886 cr | ₹5,213 cr |
| Net profit, last 12 months | ₹235 cr | ₹617 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹78 cr | ₹131 cr |
| Quarter profit vs a year earlier | -14.2% | +2.6% |
| Promoter holding | 73.15% | 29.00% |
| Health check | Average (6/10) | Strong (7.5/10) |
Common questions
Which has a higher P/E, Blue Jet Healthcare Limited or Strides Pharma Science Ltd?
Blue Jet Healthcare Limited trades at the higher P/E (37.3 against 16). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Blue Jet Healthcare Limited (19.9% against 19.7%).
Which carries more debt?
Strides Pharma Science Ltd has the higher debt-to-equity ratio (0.57 against 0.03).